AlFarhan HA, Algwaiz GF, Alzahrani HA, Alsuhaibani RS, Alolayan A, Abdelhafiz N, et al. Impact of GI Tumor Board on Patient Management and Adherence to Guidelines. J Glob Oncol. 2018;4:1–8.

Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, et al. PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations. Eur J Nucl Med Mol Imaging. 2020;47(1):51–60.

Trikalinos NA, Hammill C, Liu J, Navale P, Winter K, Chatterjee D, et al. Preliminary experience with a new institutional tumor board dedicated to patients with neuroendocrine neoplasms. Abdom Radiol. 2022;47(12):4096–102.

Article  Google Scholar 

Wang W, Tan GHC, Chia CS, Skanthakumar T, Soo KC, Teo MCC. Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Int J Hyperth. 2018;34(5):524–31.

Article  Google Scholar 

Choi SH, Yang G, Koom WS, Yang SY, Kim SS, Lim JS, et al. Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer. Cancer Med. 2023;12(22):21057–67.

Jones M, Higgs S, Dwerryhouse S, Markos V, Mason K, Green C, Nawwar A, Searle J, Lyburn I. Combined positron emissiontomography and contrast enhanced CT (PET/CeCT) is a feasible single investigation in the staging of oesophagogastric cancers: single-centrepilot study experience during the COVID-19 pandemic. The Annals of The Royal College of Surgeons of England. 2024 Sep 20;106(7):576-84.

Kroese TE, Van Hillegersberg R, Schoppmann S, Deseyne PR, Nafteux P, Obermannova R, Nordsmark M, Pfeiffer P, HawkinsMA, Smyth E, Markar S. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards inEurope. European Journal of Cancer. 2022 Mar 1;164:18-29.

Aguilar JN, Arbona JV, Soriano RM, de la Rosa JI, García-Ramos AA, Coll MC, Abadía CD, Tugores JP. Liver resectionin metastatic colorectal cancer: a multidisciplinary approach. Revista Espanola de Enfermedades Digestivas. 2005 Nov;97(11):786.

Sobhani I, Itti E, Luciani A, Baumgaertner I, Layese R, André T, et al. Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial. Ann Oncol Off J Eur Soc Med Oncol. 2018;29(4):931–7.

Rutegård MK, Båtsman M, Axelsson J, Brynolfsson P, Brännström F, Rutegård J, et al. PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study. Cancer Imaging Off Publ Int Cancer Imaging Soc. 2019;19(1):52.

Jonsson J, Hemmingsson O, Strengbom R, Axelsson J, Riklund K, Nyström H. Does 18F-FDG PET/CT change the surgical management of potentially resectable colorectal liver metastases. Scand J Surg. 2022;111(1):14574969221083144.

Article  PubMed  Google Scholar 

Kunawudhi A, Sereeborwornthanasak K, Promteangtrong C, Siripongpreeda B, Vanprom S, Chotipanich C. Value of FDG PET/contrast-enhanced CT in initial staging of colorectal cancer - comparison with contrast-enhanced CT. Asian Pac J Cancer Prev. 2016;17(8):4071–5.

PubMed  Google Scholar 

Li H, Gu GL, Li SY, Yan Y, Hu SD, Fu Z, et al. Multidisciplinary discussion and management of synchronous colorectal liver metastases: A single center study in China. World J Gastrointest Oncol. 2023;15(9):1616–25.

Patkar S, Chopde A, Shetty N, Kulkarni S, Gala KB, Chandra D, et al. Multimodality liver directed treatment for colorectal liver metastasis: Array of complementary options can improve outcomes - A single centre experience from India. Front Oncol. 2023;13:1073311.

Ma D, Zhang Y, Shao X, Wu C, Wu J. PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer. Curr Oncol. 2022;29(9):6523–39.

Bosch KD, Chicklore S, Cook GJ, Davies AR, Kelly M, Gossage JA, et al. Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment. Eur J Nucl Med Mol Imaging. 2020;47(4):759–67.

Moulton CA, Gu CS, Law CH, Tandan VR, Hart R, Quan D, et al. Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases: A Randomized Clinical Trial. JAMA. 2014;311(18):1863–9.

Schnitzer ML, von Münchhausen N, Biechele G, Runtemund J, Grawe F, Geyer T, et al. Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection. Front Oncol [Internet]. 2023 Jul 24 [cited 2025 Nov 9];13. Available from: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1161738/full

Lin ME, Castellanos CX, Acevedo JR, Yu JC, Kokot NC. Cost-Effectiveness Analysis of PET-CT Surveillance After Treatment of Human Papillomavirus-Positive Oropharyngeal Cancer. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2024;170(1):122–31.